Merck & Co Inc
XMUN:6MK
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
M
|
Merck & Co Inc
XMUN:6MK
|
US |
|
D
|
Deutsche Post AG
XMUN:DHL
|
DE |
|
R
|
Relx PLC
XMUN:RDEB
|
UK |
|
A
|
Avarone Metals Inc
CNSX:AVM.X
|
CA |
|
Siemens AG
XETRA:SIE
|
DE |
|
J
|
JCDecaux SE
XMUN:DCS
|
FR |
|
H
|
Heidelberg Materials AG
DUS:HEI
|
DE |
|
S
|
Schroders PLC
F:PYX
|
UK |
|
E
|
EDP Renovaveis SA
ELI:EDPR
|
ES |
|
P
|
Publicis Groupe SA
XMUN:PU4
|
FR |
Wall St Price Targets
6MK Price Targets Summary
Merck & Co Inc
According to Wall Street analysts, the average 1-year price target for 6MK is 111.52 EUR with a low forecast of 85.3 EUR and a high forecast of 133.01 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 6MK's stock price target?
Price Target
111.52
EUR
According to Wall Street analysts, the average 1-year price target for 6MK is 111.52 EUR with a low forecast of 85.3 EUR and a high forecast of 133.01 EUR.
What is the Revenue forecast for Merck & Co Inc?
Projected CAGR
2%
Over the last 13 years, the compound annual growth rate for Revenue has been 2%. The projected CAGR for the next 8 years is 2%.
What is the Operating Income forecast for Merck & Co Inc?
Projected CAGR
2%
Over the last 13 years, the compound annual growth rate for Operating Income has been 7%. The projected CAGR for the next 8 years is 2%.
What is the Net Income forecast for Merck & Co Inc?
Projected CAGR
4%
Over the last 13 years, the compound annual growth rate for Net Income has been 9%. The projected CAGR for the next 8 years is 4%.
